IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, today announced that Murthy Simhambhatla, President and Chief Executive Officer is scheduled to present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas, NV.

Event:               Bank of America Merrill Lynch 2018 Health Care Conference
Date:                 Thursday, May 17, 2018
Time:                10:00 a.m. PT
Location:          The Encore, Las Vegas, NV

An audio webcast of the Company’s presentation will be available on the investor relations section of Evolus’ website at www.Evolus.com. A replay of the webcast will be available for 90 days after the date of the presentation.

The Company will also be hosting one-on-one investor meetings at the conference on Wednesday, May 16. If interested in meeting with management, please reach out to Brian Johnston at bjohnston@theruthgroup.com or your Bank of America Merrill Lynch contact.

About Evolus, Inc.
Evolus is a medical aesthetics company dedicated to bringing advanced aesthetic procedures and treatments to physicians and consumers. Evolus focuses on the self-pay aesthetic market and its lead product candidate DWP-450 (prabotulinumtoxinA), an injectable 900 kDa purified botulinum toxin type A complex.

Evolus Contacts:

Media:
Kirsten Thomas, The Ruth Group
Tel: +1-508-280-6592
Email: kthomas@theruthgroup.com

Investor Contact:
Brian Johnston, The Ruth Group
Tel: +1 646-536-7028
Email: IR@Evolus.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.